Jason Gray
Foot & Ankle Surgery · Marion, INNPI 1477585396
Payments from drug & device makers
Across 27 payments — averaging $170.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Osteomed LLC$3K
- Trilliant Surgical LLC.$1K
- Johnson & Johnson$414
- Treace Medical Concepts, Inc.$292
- Medline Industries LP$125
- In2bones USA, LLC$92
- plus $181 from 6 others
Across 1 payment — averaging $1500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Skye Orthobiologics LLC$2K
What the payments were for
- Speaking & faculty fees$2,50054%
- Food & beverage$1,10324%
- Education$1,00022%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Osteomed LLC | 2 | $2,500 |
| Trilliant Surgical LLC. | 1 | $1,000 |
| Johnson & Johnson | 7 | $414 |
| Treace Medical Concepts, Inc. | 7 | $292 |
| Medline Industries LP | 1 | $125 |
| In2bones USA, LLC | 1 | $92 |
| Smith+Nephew | 2 | $49 |
| Kerecis Limited | 2 | $47 |
| Stryker | 1 | $42 |
| Integra Lifesciences Corporation | 1 | $22 |
| Misonix Inc | 1 | $12 |
| Organogenesis Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXT-Staple$2,500
- EXT-Encompass$1,500
- EXT-ExtremiLock Ankle$1,500
- Arsenal$1,000
- EXT-InterPhlex$1,000
- NA$145
- Hyalomatrix Wound Device$125
- Lapiplasty System$115
How this compares
$4,603 in reported general payments places this provider in the 50th percentile of 212 foot & ankle surgery providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 15 | $14,915 |
| Doxycycline Hyclate | 41 | $317 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 24 | $149 |
| Silver Sulfadiazine | 21 | $126 |
| Ciclopirox | 12 | $114 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 18 | $84 |
| Tramadol Hcl | 12 | $15 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Marion
- Steven HerbstMuncie$1.6M
- Douglas BlacklidgeKokomo$689K
- Patrick DeheerIndianapolis$493K
- Scott NevilleMooresville$353K
- Travis MontgomeryWestfield$345K
- Robert Clemency IiiSchererville$215K
- William AdamsGreenfield$178K
- Christopher WintersCarmel$158K
- Steven DouthettFort Wayne$153K
- Brian ElliottShelbyville$142K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.